Atea Pharmaceuticals, Inc.
AVIRFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Atea Pharmaceuticals, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Source: Atea Pharmaceuticals, Inc. — 10-K filed Feb 28, 2023
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 8 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 23, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 2026-03-31 | 81,835 | $440K | SEC filing |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 2026-03-31 | 33,751 | $182K | SEC filing |
| Certified Advisory Corp | 2026-03-31 | 24,500 | $132K | SEC filing |
| HSBC HOLDINGS PLC | 2026-03-31 | 258,989 | $1.38M | SEC filing |
| STATE OF WISCONSIN INVESTMENT BOARD | 2026-03-31 | 99,803 | $537K | SEC filing |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2026-03-31 | 596,709 | $3.21M | SEC filing |
| ROYAL BANK OF CANADA | 2026-03-31 | 282 | Not shown | SEC filing |
| IFP Advisors, Inc | 2026-03-31 | 4 | $22 | SEC filing |
| SBI Securities Co., Ltd. | 2026-03-31 | 2 | $11 | SEC filing |
| Squarepoint Ops LLC | 2026-03-31 | 55,098 | $296K | SEC filing |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2026-03-31 | 106,562 | Not shown | SEC filing |
| Jump Financial, LLC | 2026-03-31 | 93,247 | $502K | SEC filing |
| PNC FINANCIAL SERVICES GROUP, INC. | 2026-03-31 | 3,076 | $16.5K | SEC filing |
| MAI Capital Management | 2026-03-31 | 132 | $711 | SEC filing |
| TANG CAPITAL MANAGEMENT LLC | 2026-03-31 | 4,814,700 | $25.9M | SEC filing |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 2026-03-31 | 210,542 | $1.13M | SEC filing |
| BANK OF AMERICA CORP /DE/ | 2026-03-31 | 105,640 | $568K | SEC filing |
| AMERICAN CENTURY COMPANIES INC | 2026-03-31 | 167,230 | $900K | SEC filing |
| Rockefeller Capital Management L.P. | 2026-03-31 | 4,822 | $25.9K | SEC filing |
| Essential Partners LLC | 2026-03-31 | 49 | $264 | SEC filing |
- Each value is checked against Atea Pharmaceuticals, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 1 row: the filed value is about 1,000 times too small for the share count at Atea Pharmaceuticals, Inc.'s share price.
- Value not shown for 1 row: the value per share could not be confirmed against the share prices on file from within three months of the report date.
120 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Atea Pharmaceuticals, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2024-12-10 · BERGER FRANKLIN M: Larger than all 13 other insider sales of Common Stock on file. SEC filing
- 2024-02-01 · Sommadossi Jean-Pierre: Larger than 12 of the 13 other insider sales of Common Stock on file. SEC filing
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-05-18 (amended) | Murphy Polly A. · Director | Common Stock | P — Open market or private purchase | +6,100 | 4.17 | SEC filing |
| 2025-05-18 | Murphy Polly A. · Director | Common Stock | P — Open market or private purchase | +6,100 | 4.17 | SEC filing |
| 2025-01-16 (amended) | BERGER FRANKLIN M · Director | Common Stock | P — Open market or private purchase | +10,000 | 3.36 | SEC filing |
| 2025-01-16 | BERGER FRANKLIN M · Director | Common Stock | P — Open market or private purchase | −10,000 | 3.36 | SEC filing |
| 2025-01-15 (amended) | BERGER FRANKLIN M · Director | Common Stock | P — Open market or private purchase | +15,000 | 3.19 | SEC filing |
| 2025-01-15 | BERGER FRANKLIN M · Director | Common Stock | P — Open market or private purchase | −15,000 | 3.19 | SEC filing |
| 2024-12-10 | BERGER FRANKLIN M · Director | Common Stock | S — Open market or private sale | −359,606 | 2.85 | SEC filing |
| 2024-09-19 | Sommadossi Jean-Pierre · President, CEO, and Chairman | Common Stock | S — Open market or private sale | −1,841 | 4.00 | SEC filing |
Showing 8 of 19 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-18 | Polsky Bruce · Director | Common Stock | M — Exercise or conversion of derivative security | +29,600 | SEC filing |
| 2026-06-18 | Lucidi Bruno · Director | Restricted Stock Units | M — Exercise or conversion of derivative security | −29,600 | SEC filing |
| 2026-06-18 | Adams Jerome M. · Director | Common Stock | M — Exercise or conversion of derivative security | +29,600 | SEC filing |
| 2026-06-18 | Adams Jerome M. · Director | Restricted Stock Units | M — Exercise or conversion of derivative security | −29,600 | SEC filing |
| 2026-06-18 | Murphy Polly A. · Director | Restricted Stock Units | M — Exercise or conversion of derivative security | −29,600 | SEC filing |
| 2026-06-18 | BERGER FRANKLIN M · Director | Common Stock | M — Exercise or conversion of derivative security | +29,600 | SEC filing |
| 2026-06-18 | BERGER FRANKLIN M · Director | Restricted Stock Units | M — Exercise or conversion of derivative security | −29,600 | SEC filing |
| 2026-06-18 | Murphy Polly A. · Director | Common Stock | M — Exercise or conversion of derivative security | +29,600 | SEC filing |
Showing 8 of 30 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.